FAU seeks volunteers for Alzheimer's study
Florida Atlantic University’s Charles E. Schmidt College of Biomedical Science is seeking volunteers to take part in an Alzheimer’s medication study. The late-stage clinical trial is sponsored by Eli Lilly and Company and will study the effects of semagacestat, a new drug designed to slow the progression of Alzheimer’s.
“The current available treatments for Alzheimer’s disease do not address the development of amyloid plaques. If these new medications prove to be safe and effective, it will truly represent a game-changing breakthrough in the treatment of this devastating disease,” said FAU clinical assistant professor of biomedical science Peter J. Holland.
Volunteers must be 55 or older with mild to moderate Alzheimer’s and have a caregiver who spends at least 10 hours a week with them. For more information, call Michelle Owens at 561-297-0164 or e-mail at email@example.com.